An innovative home-based internet health service project to improve outcomes for Haematopoietic Stem Cell Transplant survivors

Not Applicable

Completed

• Conditions: Allogeneic Haematopoietic Stem Cell Transplant patients; Blood - Haematological diseases; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12613001054707
• Lead Sponsor: St Vincent's Hospital, Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-09-23
• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

Allogeneic HSCT patients, > 6 months post-transplant with no severe GVHD or other medical issues that requires regular clinic visits, no physical or mental impediments to carry out the programmes or assessment tasks,

Exclusion Criteria

has cardiac disease including arrhythmia,living alone and not approved by the patient’s haematologist.

Study & Design

• Study Type: Interventional
• Study Design: Not specified